Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Selective Targeting of Histone Deacetylase 11 Disables Metabolism of Myeloproliferative Neoplasms

Blood (2019) 134 (Supplement_1): 474.

https://doi.org/10.1182/blood-2019-127235

Published: 2019

Journal Articles

Characterization of Interaction of Factor VIII with Engineered Variants of a Single-Chain Variable Antibody Fragment

Svetlana A Shestopal, PhD, Leonid A Parunov, PhD, Mikhail V Ovanesov, PhD, Timothy K Lee, PhD, Andrey G Sarafanov, PhD

Blood (2018) 132 (Supplement 1): 1170.

https://doi.org/10.1182/blood-2018-99-115455

Published: 2018

Journal Articles

GO-8: Preliminary Results of a Phase I/II Dose Escalation Trial of Gene Therapy for Haemophilia a Using a Novel Human Factor VIII Variant

Amit C Nathwani, MD PhD, Edward Tuddenham, MD, Pratima Chowdary, MD, Jenny McIntosh, PhD, Doyoung Lee, PhD, Cecilia Rosales, PhD, Mark Phillips, Jun Pie, Zhou Junfang, Michael M Meagher, PhD, Ulrike Reiss, MD, Andrew M. Davidoff, MD, Chris L Morton, Anne Riddell

Blood (2018) 132 (Supplement 1): 489.

https://doi.org/10.1182/blood-2018-99-118256

Published: 2018

Journal Articles

Safety and Efficacy of an Adeno Associated Virus-Based Vector Carrying the Human Clotting Factor IX Gene (AAV5-hFIX) As Studied in Non-Human Primates

Bart Nijmeijer, PhD, Harald Petry, PhD, Lisa Spronck, Corina Van Der Kruijssen, Jorgen Petersen, MD PhD, Florence Salmon, PhD

Blood (2014) 124 (21): 4800.

https://doi.org/10.1182/blood.V124.21.4800.4800

Published: 2014

Journal Articles

Phase 1-2 Clinical Trial of a Recombinant AAV5 Vector Containing the Human FIX Gene in Patients with Severe or Moderately Severe Haemophilia B

Wolfgang A. Miesbach, MD PhD, Christian Meyer, MD PhD, Bart Nijmeijer, PhD, Florence Salmon, PhD, Nadina Grosios, PhD, Harald Petry, PhD, Frank W.G. Leebeek, MD PhD

Blood (2014) 124 (21): 5948.

https://doi.org/10.1182/blood.V124.21.5948.5948

Published: 2014

Journal Articles

Identification and Characterization Of a Potent FLT3 Inhibitor

Yun Chen, Yao Guo, Wanting Ho, Zhizhuang Joe, Zhao, PhD

Blood (2013) 122 (21): 5027.

https://doi.org/10.1182/blood.V122.21.5027.5027

Published: 2013

Journal Articles

MAGE-A3 Recombinant Protein (recMAGE-A3) Immunotherapy and Autologous Peripheral Blood Lymphocyte (PBL) Infusion Is Safe and Induces Robust Humoral Immune Responses In Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplantation (autoSCT)

Adam D Cohen, MD, Nikoletta Lendvai, MD PhD, Sacha Gnjatic, Ph.D., Achim A Jungbluth, MD, Stephane Bertolini, Linda Pan, Pharm.D., Ralph Venhaus, Ioanna Tsakos, Katarzyna Garcia, MS, Linda Thibodeau, RN, Katherine Alpaugh, PhD, Nailah Cummings, Rafik Fellague-Chebra, MD, Olivier Gruselle, Hearn J. Cho, MD, PhD

Blood (2013) 122 (21): 154.

https://doi.org/10.1182/blood.V122.21.154.154

Published: 2013

Journal Articles

Characterization of Molecular Interaction of Blood Coagulation Factor VIII and Its Clearance Receptor, Low-Density Lipoprotein Receptor.

James H Kurasawa, MS, Svetlana A Shestopal, Ph.D., Elena Karnaukhova, Ph.D., Evi B Struble, PhD, Timothy K Lee, PhD, Andrey G Sarafanov, Ph.D.

Blood (2012) 120 (21): 2206.

https://doi.org/10.1182/blood.V120.21.2206.2206

Published: 2012

Journal Articles

Inhibitory Effect of an Anti-Factor VIII Antibody Fragment On Factor VIII Activity in Different Functional Assays

Mikhail V Ovanesov, PhD, James H Kurasawa, MS, Naveen Jha, PhD, Svetlana A Shestopal, PhD, Timothy K Lee, PhD, Andrey G Sarafanov, Ph.D.

Blood (2012) 120 (21): 4387.

https://doi.org/10.1182/blood.V120.21.4387.4387

Published: 2012

Journal Articles

Expression of the Light Chain of Coagulation Factor VIII in Insect Cells

Svetlana A Shestopal, PhD, James H Kurasawa, MS, Timothy K Lee, PhD, Andrey G Sarafanov, PhD

Blood (2011) 118 (21): 2269.

https://doi.org/10.1182/blood.V118.21.2269.2269

Published: 2011

Journal Articles

Inactivation of Polycomb Repressive Complex 2 Components in Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms

Nicholas C.P. Cross, PhD, FRCPath, Joannah Score, PhD, Claire Hidalgo-Curtis, PhD, Amy V Jones, PhD, Nils Winkelmann, MD, Alison Skinner, BSc, Daniel Ward, MSc, Katerina Zoi, MD, PhD, Thomas Ernst, MD, Frank Stegelmann, MD, Konstanze Dohner, MD, PhD, Andrew J Chase, PhD

Blood (2011) 118 (21): 617.

https://doi.org/10.1182/blood.V118.21.617.617

Published: 2011

Journal Articles

Changes In Apoptotic Gene Expression Profile In CLL Patients Treated with Cladribine, Cyclophosphamide and Rituximab (CCR)

Ida Franiak-Pietryga, Aleksandra Salagacka, Henryk Maciejewski, Jerzy Z. Blonski, Aleksandra Kotkowska, Marek Mirowski, Tadeusz Robak, Anna Korycka-Wolowiec

Blood (2010) 116 (21): 2469.

https://doi.org/10.1182/blood.V116.21.2469.2469

Published: 2010

Journal Articles

Compound Heterozygosity of a W493C Substitution and R704/Premature Stop Codon within the γ-Glutamyl Carboxylase in Combined Vitamin K-Dependent Coagulation Factor Deficiency in a French Family.

Dhouha Darghouth, PhD, Kevin W Hallgren, Odile Issertial, Amine Bazaa, PhD, Kathleen L Berkner, PhD, Jean-Philippe Rosa, MD, PhD, Rémi Favier, MD

Blood (2009) 114 (22): 1302.

https://doi.org/10.1182/blood.V114.22.1302.1302

Published: 2009

Journal Articles

Soluble GM-CSF Receptor α Is Cytotoxic to Myeloid Cells in a Manner That Is Independent of GM-CSF Binding Inhibition.

Jeffrey R Gardner, BS, MBA, Mark Lawrence Heaney, MD, PhD, Linghao Niu, PhD

Blood (2009) 114 (22): 3618.

https://doi.org/10.1182/blood.V114.22.3618.3618

Published: 2009

Journal Articles

Post Transplant Allogeneic Antibody Responses Form against Annexin 8

George L. Chen, M.D., Nilou Arden, PhD, David Miklos, MD, PhD

Blood (2008) 112 (11): 4605.

https://doi.org/10.1182/blood.V112.11.4605.4605

Published: 2008

Journal Articles

Allogeneic Antibodies Identify GVL Targets CHAF1b and NuSAP1 in AML Patients.

Persis P. Wadia, Ph.D, Marc A. Coram, Ph.D, Atul J. Butte, MD, Ph.D, David B. Miklos, MD, PhD

Blood (2007) 110 (11): 168.

https://doi.org/10.1182/blood.V110.11.168.168

Published: 2007

Journal Articles

Identification of a Protein S-Interactive Site on the Factor VIII A2 Domain.

Masahiro Takeyama, MD, Keiji Nogami, MD, PhD, Tetsuhiro Soeda, Akira Yoshioka, MD, PhD, Midori Shima, MD, PhD

Blood (2007) 110 (11): 2684.

https://doi.org/10.1182/blood.V110.11.2684.2684

Published: 2007

Journal Articles

Contributions of Residues in the 558-Loop of Factor VIIIa A2 Subunit to Interactions with Factor IXa in Factor Xase.

H. Travis Ichikawa, Ph.D., Sandeep Chadha, MS, Qian Zhou, M.S., Philip J. Fay, Ph.D.

Blood (2007) 110 (11): 2688.

https://doi.org/10.1182/blood.V110.11.2688.2688

Published: 2007

Journal Articles

A Cluster of Basic Residues in the Factor VIIIa A2 Subunit Function in Substrate Binding and Product Release during the Activation of Factor X by Factor Xase.

H. Travis Ichikawa, PhD, Qian Zhou, M. S., Philip J. Fay, Ph. D.

Blood (2006) 108 (11): 196.

https://doi.org/10.1182/blood.V108.11.196.196

Published: 2006

Journal Articles

In Vitro Reconstitution of the NALP1 Inflammasome Reveals Requirements for Caspase Activation.

Benjamin Faustin, PhD, Lydia Lartigue, Ph.D., Jean-Marie Bruey, Ph.D., Frederic Luciano, Ph.D., Dorit Hanein, Ph.D., Isabelle Rouiller, Ph.D., John C. Reed, MD, Ph.D.

Blood (2006) 108 (11): 3658.

https://doi.org/10.1182/blood.V108.11.3658.3658

Published: 2006

NARROW

Selective Targeting of Histone Deacetylase 11 Disables Metabolism of Myeloproliferative Neoplasms

Characterization of Interaction of Factor VIII with Engineered Variants of a Single-Chain Variable Antibody Fragment

GO-8: Preliminary Results of a Phase I/II Dose Escalation Trial of Gene Therapy for Haemophilia a Using a Novel Human Factor VIII Variant

Safety and Efficacy of an Adeno Associated Virus-Based Vector Carrying the Human Clotting Factor IX Gene (AAV5-hFIX) As Studied in Non-Human Primates

Phase 1-2 Clinical Trial of a Recombinant AAV5 Vector Containing the Human FIX Gene in Patients with Severe or Moderately Severe Haemophilia B

Identification and Characterization Of a Potent FLT3 Inhibitor

MAGE-A3 Recombinant Protein (recMAGE-A3) Immunotherapy and Autologous Peripheral Blood Lymphocyte (PBL) Infusion Is Safe and Induces Robust Humoral Immune Responses In Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplantation (autoSCT)

Characterization of Molecular Interaction of Blood Coagulation Factor VIII and Its Clearance Receptor, Low-Density Lipoprotein Receptor.

Inhibitory Effect of an Anti-Factor VIII Antibody Fragment On Factor VIII Activity in Different Functional Assays

Expression of the Light Chain of Coagulation Factor VIII in Insect Cells

Inactivation of Polycomb Repressive Complex 2 Components in Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms

Changes In Apoptotic Gene Expression Profile In CLL Patients Treated with Cladribine, Cyclophosphamide and Rituximab (CCR)

Compound Heterozygosity of a W493C Substitution and R704/Premature Stop Codon within the γ-Glutamyl Carboxylase in Combined Vitamin K-Dependent Coagulation Factor Deficiency in a French Family.

Soluble GM-CSF Receptor α Is Cytotoxic to Myeloid Cells in a Manner That Is Independent of GM-CSF Binding Inhibition.

Post Transplant Allogeneic Antibody Responses Form against Annexin 8

Allogeneic Antibodies Identify GVL Targets CHAF1b and NuSAP1 in AML Patients.

Identification of a Protein S-Interactive Site on the Factor VIII A2 Domain.

Contributions of Residues in the 558-Loop of Factor VIIIa A2 Subunit to Interactions with Factor IXa in Factor Xase.

A Cluster of Basic Residues in the Factor VIIIa A2 Subunit Function in Substrate Binding and Product Release during the Activation of Factor X by Factor Xase.

In Vitro Reconstitution of the NALP1 Inflammasome Reveals Requirements for Caspase Activation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only